Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['cilta-cel', 'mmsm']
headline: significant pfs improvement with cilta-cel compared to dpd or pvd important to note statistical mischievousness given early progressions (see fineprint) so hr is exaggerated - but even the hr including all patients was said to be significantly improved #asco23 #mmsm 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem